Institution: | 1. Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Interventional Neuroradiology Department, Hôpital Fondation Ophtalmologique Adolphe de Rothschild, Paris, France;2. Department of Diagnostic and Therapeutic Neuroradiology, Université de Lorraine, CHRU-Nancy, Nancy, France;3. Division of Neurology, Department of Neurology, Stroke Centre, Foch Hospital, University Versailles Saint-Quentin en Yvelines, Suresnes, France;4. Stroke Unit, CHU Bordeaux, Université de Bordeaux, Bordeaux, France;5. Department of Neurology, Université de Lorraine, CHRU-Nancy, Nancy, France;6. Department of Biostatistics, CHU Lille, Lille, France;7. Interventional Neuroradiology Department, Hôpital Fondation Ophtalmologique Adolphe de Rothschild, Paris, France
Université de Paris Cité, Paris, France
FHU NeuroVasc, Paris, France
Laboratory of Vascular Translational Science, INSERM U1148, Paris, France;8. Interventional Neuroradiology Department, Hôpital Fondation Ophtalmologique Adolphe de Rothschild, Paris, France
FHU NeuroVasc, Paris, France
Laboratory of Vascular Translational Science, INSERM U1148, Paris, France;9. Nephrology Department, Tours Hospital, Tours, France
Université de Tours, Tours, France
EA4245-Transplantation, Immunology and Inflammation, University of Tours, Tours, France;10. Interventional Neuroradiology Department, Hôpital Fondation Ophtalmologique Adolphe de Rothschild, Paris, France
Université de Paris Cité, Paris, France
FHU NeuroVasc, Paris, France
Laboratory of Vascular Translational Science, INSERM U1148, Paris, France
Department of Neurology, Hopital Lariboisière, APHP Nord, Paris, France;11. Interventional Neuroradiology Department, Hôpital Fondation Ophtalmologique Adolphe de Rothschild, Paris, France;12. See the Appendix 13. A for the BP TARGET investigators. |